SecBot SecBot
8-K ·Filed Jun 9, 2026

ZEOX

Zeo ScientifiX, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago SEC0001829126-26-006218
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine advisory board expansion with no immediate financial read-through. Monitor future 10-Q or 10-K for any revenue impact from expanded physician network or educational programming.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ZEOX ▼ -28.14% at T+60d
NEUTRAL call -28.14% · α vs SPY -32.23% · entry $1.67 → $1.20
Entry = T+0 close
Jun 9, 2026
via day close
T+1d
+7.78%
call +7.78% · α +9.36%
$1.80
settled 5mo ago
T+5d
+2.99%
call +2.99% · α +1.19%
$1.72
settled 4mo ago
T+20d
+7.78%
call +7.78% · α +6.39%
$1.80
settled 4mo ago
T+60d
-28.14%
call -28.14% · α -32.23%
$1.20
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Zeo ScientifiX announced the expansion of its Medical Advisory Board with nine new physicians and scientists in regenerative and longevity medicine. This is a routine organizational update with no financial terms or material business impact disclosed.

Key Facts

  • Medical Advisory Board expanded by nine members on June 9, 2026
  • New members include specialists in orthopedics, oncology, longevity, pain management, plastic surgery, and biologic therapies
  • Board will provide strategic guidance on scientific development, clinical protocols, and physician education
  • No financial terms, compensation, or revenue impact disclosed

Financial Impact

No financial impact disclosed

Risk Factors

  • No material financial or operational changes from this filing
  • Forward-looking statements about regenerative medicine legislation are speculative

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-006218
Document: zeoscientifix_ex99-1.htm0001829126-26-006218
Document: 0001829126-26-006218-index-headers.html0001829126-26-006218
Document: 0001829126-26-006218-index.html0001829126-26-006218
Document: 0001829126-26-006218.txt0001829126-26-006218
14 reports for ZEOX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +13.87%Apr 9, 2026
Filters
Rows
Reports for ZEOX — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
8-K
NEUTRAL ★ 5/10
$1.48awaiting T+20—$1.18 (−20.27%)
Sep 15, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$1.36 $1.15▼ −15.44%▼ −18.42%$1.18 (−13.24%)
Sep 1, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$1.20 $1.39▲ +15.83%▲ +14.65%$1.18 (−1.67%)
Aug 4, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$1.40 $1.20▼ −14.16%▼ −12.93%$1.18 (−15.59%)
Jul 21, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$1.69 $1.55▼ −8.28%▼ −10.85%$1.18 (−30.18%)
Jul 8, 2026
15w ago
8-K
BULLISH ★ 5/10
$1.80 $1.40▼ −22.33%▼ −25.61%$1.18 (−34.44%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 1/10
$1.77 $1.65▼ −6.78%▼ −4.59%$1.18 (−33.33%)
Jun 16, 2026
19w ago
8-K
NEUTRAL ★ 2/10
$1.72 $1.94▲ +12.79%▲ +11.93%$1.18 (−31.40%)
Jun 9, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$1.67 $1.80▲ +7.78%▲ +6.39%$1.18 (−29.34%)
May 27, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$1.85 $1.70▼ −8.11%▼ −6.21%$1.18 (−36.22%)
Showing 10 of 14

US Market Status

Market Open — Closes in 2h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026